E-cigarettes declared a health threat by California health officials
the ONA take:
The California Department of Public Health has released a report that declares e-cigarettes a health threat that contributes to the emission of cancer-causing chemicals and addiction to nicotine.
“E-cigarettes are not as harmful as conventional cigarettes, but e-cigarettes are not harmless,” said California Health Officer Ron Chapman. He believes that younger generations will become addicted to nicotine if e-cigarettes continue to remain unregulated.
Approximately 17 percent of high school seniors had reported using e-cigarettes in the last year, according to the report. Although California has banned the sale of e-cigarettes to minors as of 2010, reports of children under 5 with e-cigarette poisoning jumped from seven in 2012 to 154 just last year.
However, such concerns have been met with criticism from the American Vaping Association, an advocacy group for e-cigarettes.
“Despite the health officer’s false claims, there is ample evidence that ‘vaping’ helps smokers quit and is far less hazardous than smoking,” said Gregory Conley, president of the AVA.
Although Chapman has not taken an open position on any specific legislation, he plans to roll out an e-cigarette awareness campaign that could potentially include television and radio advertisements.
California Department of Public Health released a report that declares e-cigarettes a health threat.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|